Did you join us earlier this year at the MassBio State of Possible Conference 2024? If you missed it or want to look back, you can find all of the session recordings on MB Vision - including remarks from Congressman Jake Auchincloss. In his speech, he spoke to Massachusetts’ historic tendency to be a national leader, asserting that the state’s approach to biotechnology should not be any different. He conveyed the need for American leadership in biotechnology innovation, calling on his colleagues in Congress to prioritize biotechnology the same way semiconductor technologies and production were prioritized. Watch the full recording on #MBVision https://lnkd.in/efgUy8Gc. #StateOfPossible24
MassBio
Biotechnology Research
Cambridge, Massachusetts 33,282 followers
Massachusetts is the State of Possible - the #1 life sciences cluster in the world - and we plan to keep it that way!
About us
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
- Website
-
http://www.massbio.org
External link for MassBio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Nonprofit
- Founded
- 1985
Locations
-
Primary
700 Technology Sq
5th Floor
Cambridge, Massachusetts 02139, US
Employees at MassBio
-
Carolina Alarco
Biotech/Medtech Executive and Board Member, Strategic Consultant, Investment Banking, Angel Investor
-
Joel Kahn MD, NBC-HWC
Innovation driven health executive
-
Joseph Murphy
Founder and President at immunePCS, LLC
-
Rita McAteer
Accomplished marketing, communications and fundraising leader.
Updates
-
We're pretty fond of our newest #MassBioMembers. Can you show them some love on this #WelcomeWednesday? Amplitude Therapeutics is a seed-staged biotechnology company focusing on developing the next generation of RNAs to fully unlock the therapeutic potential of RNA biology. GreenLabs Recycling collects and recycles non-hazardous plastic consumables from labs, recognizing that by keeping recycling local, we can make it effective in terms of cost and environmental sustainability. ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products. IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences is one of the most successful Czech research institutions, recognized globally. This year, it established its first laboratory in the United States right here in Cambridge. IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Jett Foundation empowers people and families impacted by Duchenne muscular dystrophy through the development of transformative programming, educational opportunities, and ongoing support. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to safely and precisely restoring health in patients with severe conditions. seqWell creates scalable genomics technologies that simplify workflows and help enable every life scientist to unlock transformative discoveries with sequencing. Skylark Bio, Cambridge MA Skylark Bio, a gene therapy company, exists to create a world where anyone, anywhere can experience life in all its sensory dimensions. Vindhya Data Science is an innovative data science company specializing in bioinformatics, genomics, machine learning, artificial intelligence, structural biology and the full spectrum of computational biology. Viva Biotech provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We're so excited to have you join the MassBio community!
-
Today, MassBio and The Termeer Foundation announced the launch of “CEO & Founder Link,” a dedicated network for founders and CEOs of emerging #lifesciences companies (Press Release: https://lnkd.in/eFCczR4Y). Through quarterly engagements, the two influential organizations will provide leaders with networking, education around key topics, and a peer community with whom they can collaborate. Founders and CEOs are invited to apply through an online portal to attend events where you will feel empowered and safe to share best practices, workshop challenges, and forge lasting connections. Apply now: https://lnkd.in/edatZS3J.
-
It was so much fun hosting Ticket to Biotech's regional meetup in the #MassBioHub! Appreciate the opportunity to host so many of the industry's storytellers to network and exchange business cards, as well as complete a service project with Life Science Cares Boston. Thanks to our friends at The Castle Group and #MassBioMember AbbVie for sponsoring. Looking forward to hosting future events that bring together the people and teams who help the #biopharma industry share our #patientdriven stories. Stay tuned! #T2Bmeet
Thanks to everyone who came out this week to support Life Science Cares Boston and our community for T2Bmeet @ Boston! Such a great turnout for a summer morning, including three of our fabulous ad board members- Sarah MacDonald, Trista Morrison, NACD.DC, and Cynthia Clayton. We couldn’t have done it without our amazing hosts, Ryan Boehm, Benjamin Bradford and the MassBio team, and generous sponsors, The Castle Group and AbbVie! Special thanks to the Castle crew who came out in force to join us for our first Boston event- David Tanklefsky, Sandy Lish, Danielle Dickinson, CMP, Justin Auguste. If you missed this one, don’t worry- there will be more in Boston and other biopharma hubs. Have a fantastic weekend!
-
BioversityMA is positively impacting the lives of their graduates and the Massachusetts life sciences community. Join their inaugural fundraising event on July 31: https://lnkd.in/eFG-NJtx. Reach out to Zach Stanley to learn more about sponsoring this event and the program.
CEO & President, MassBio | Chair, Bioversity | Board, The Boston Foundation | Vice Chair, American Cancer Society (ACS) Eastern New England | Board, MassBioEd Foundation
Launching BioversityMA was a leap of faith. Opening the physical doors was a thrill. Seeing the tangible impact on the lives of residents? Priceless. After just 6 months, it’s incredible to be able to celebrate the 43 individuals who have graduated, many who have been hired. But doing this work—training the students, paying their stipends and expenses, keeping the lights on—has a cost to it. What is the value of bringing new talent into the local #lifesciences workforce and making progress in our responsibility to be an inclusive industry? Join us on July 31 as we celebrate Bioversity’s progress and raise funds for its future (Tickets: https://lnkd.in/e8eigKMz). Bioversity’s future is now linked to the futures of the passionate individuals who want to make a difference for patients while they make a difference for themselves and their families. Buy a ticket. Make a donation. Be a sponsor. MassBio | Zach Stanley | Ross Marshall #bioversity #workforcedevelopment #workforcetraining #nonprofit
-
Since our last #FundingFriday post, we've seen local companies report more than $140M in funds raised, including Apriori Bio's $1.1M to continue the development of their biology-informed artificial intelligence platform geared toward pandemic preparedness. Boston-based Exsilio Therapeutics emerged from stealth in late June with $82M in Series A financing to develop its genomic medicine (https://lnkd.in/gbMM7nBw), while another Boston company, GALY, brought in a $31.4M Series B.
-
MassBio is proud to announce Service Insight, a leading innovator in AIoT powered asset management and monitoring solutions, as the Preferred Lab Operations Platform Partner for the #MassBioEdge program. For more information about Service Insight and its innovative lab operations platform, visit their listing on the Edge Connector site: https://lnkd.in/eHEKhnPq. #AIoT #IoT
MassBio’s collaboration with Service Insight is a game-changer for our members. Their platform’s ability to integrate multiple facets of lab management into one cohesive system will significantly enhance the operational capabilities of our life sciences community. This #MassBioEdge partnership exemplifies our commitment to equipping our members with the best tools available to advance their scientific endeavors. https://lnkd.in/e4KPwYTY
Introducing our New MassBioEdge Preferred Partner in Lab Operations: Service Insight - MassBio
https://www.massbio.org
-
Courtesy of our MassBioEdge Preferred Partner Veolia, we are pleased to offer free U.S. DOT Hazmat training for the packaging and transportation of regulated medical waste. This training, will be held virtually on July 23 at 11 AM. Don’t miss this opportunity to stay compliant and informed. Register today: https://lnkd.in/edWnNZYJ
-
This is your last chance to register for Daiichi Sankyo US’s #PharmaDay on Tuesday, July 16. Ahead of the event, we sat down with Ken Takeshita, Global Head of Research & Development for Daiichi Sankyo, about their approach to innovation and partnering: https://lnkd.in/eEVpBd8z Don’t miss out on this opportunity to connect with Daiichi Sankyo’s leadership and learn more about their research. Register now: https://lnkd.in/emvzeGsc
-
MassBio reposted this
CEO & President, MassBio | Chair, Bioversity | Board, The Boston Foundation | Vice Chair, American Cancer Society (ACS) Eastern New England | Board, MassBioEd Foundation
The power of the Massachusetts ecosystem to attract federal dollars is shows its strength in discovery, research, and development. This was on display for the world to see during COVID, it was a driving factor in winning the ARPA-H hub, and it's clear that preparations for future outbreaks is our charge and responsibility. https://lnkd.in/ePtWBr2P
As bird flu spreads in U.S., feds award Moderna $176M to work on vaccine - Boston Business Journal
bizjournals.com